Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma

被引：23

作者：

Nastoupil, Loretta J. ^{[1
,3
]}

Bartlett, Nancy L. ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[2] Washington Univ, Siteman Canc Ctr, St Louis, MO USA

[3] Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Unit 429, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 04期

关键词：

RITUXIMAB PLUS CYCLOPHOSPHAMIDE; PREVIOUSLY UNTREATED PATIENTS; SOUTHWEST-ONCOLOGY-GROUP; NON-HODGKIN-LYMPHOMA; DOUBLE-HIT LYMPHOMA; SINGLE-ARM; OPEN-LABEL; ELDERLY-PATIENTS; PHASE-III; R-CHOP;

D O I：

10.1200/JCO.22.01848

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Diffuse large B-cell lymphoma, the most common subtype of non-Hodgkin lymphoma, comprises a heterogenous group of morphologically, genetically, and clinically distinct diseases. Several recent advances have affected the treatment landscape, which had been mostly stagnant for the past few decades. We will review the practice-changing studies in frontline (POLARIX), early relapse (ZUMA-7 and TRANSFORM), and multiple recurrent (ZUMA-1, JULIET, TRANSCEND, L-MIND, and LOTIS-2) stages and discuss how the treatment landscape may evolve with the emergence of bispecific antibodies.

引用

页码：903 / +

页数：12

共 50 条

[21] Diffuse large B-cell lymphoma
Martelli, Maurizio
Ferreri, Andres J. M.
Agostinelli, Claudio
Di Rocco, Alice
Pfreundschuh, Michael
Pileri, Stefano A.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (02) : 146 - 171
[22] Diffuse large B-cell lymphoma
Decool, Gauthier
Theves, Floriane
HEMATOLOGIE, 2018, 24 : 35 - 40
[23] Diffuse Large B-Cell Lymphoma
Lang, Raynell
Gill, M. John
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23): : 2261 - 2262
[24] Diffuse Large B-Cell Lymphoma
Friedberg, Jonathan W.
Fisher, Richard I.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 941 - +
[25] Diffuse large B-cell lymphoma
Shahi, Parham Khosravi
Manga, Gumersindo Perez
MEDICINA CLINICA, 2006, 127 (01): : 17 - 21
[26] Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers
El Hussein, Siba
Shaw, Kenna R. M.
Vega, Francisco
MODERN PATHOLOGY, 2020, 33 (12) : 2422 - 2436
[27] Diffuse large B-cell lymphoma
Alcantara, Marion
Huynh, Tony
HEMATOLOGIE, 2016, 22 (02): : 159 - 166
[28] Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
Roschewski, Mark
Phelan, James D.
Wilson, Wyndham H.
CANCER JOURNAL, 2020, 26 (03): : 195 - 205
[29] Translating the Biology of Diffuse Large B-cell Lymphoma Into Treatment
Danilov, Alexey, V
Magagnoli, Massimo
Matasar, Matthew J.
ONCOLOGIST, 2022, 27 (01): : 57 - 66
[30] NOVEL THERAPIES IN THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA
Carlo-Stella, C.
Calabretta, E.
HAEMATOLOGICA, 2021, 106 (10) : 201 - 202

← 1 2 3 4 5 →